openPR Logo
Press release

D-Mannose Market Expected to Reach US$ 1.72 Billion by 2034 | Fact.MR

06-17-2025 07:28 PM CET | Food & Beverage

Press release from: Fact.MR

The global D-Mannose market is poised for steady growth, with a projected market value of US$ 1.3 billion in 2024, expected to expand at a compound annual growth rate (CAGR) of 2.9% to reach US$ 1.72 billion by 2034. According to a comprehensive report by Fact.MR, the increasing consumer preference for natural and plant-based supplements, particularly for urinary tract health, is driving this market expansion. This press release highlights the key trends, drivers, and opportunities shaping the D-Mannose market, based exclusively on insights from the Fact.MR report.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9923

Market Overview

D-Mannose, a naturally occurring sugar found in fruits such as blueberries, cranberries, and pineapples, is gaining significant traction in the health and wellness industry due to its role in supporting urinary tract health. Known for its ability to prevent bacteria, such as E. coli, from adhering to the urinary tract walls, D-Mannose is widely used as a food source for the prevention and treatment of urinary tract infections (UTIs). The rising global prevalence of UTIs, particularly among women and diabetic patients, combined with a shift toward natural remedies, is fueling demand for D-Mannose products.

Key Market Drivers

1. Increasing Prevalence of Urinary Tract Infections

The growing incidence of UTIs worldwide is a primary driver of the D-Mannose market. UTIs are particularly common among women and individuals with diabetes, who are more susceptible due to physiological factors. D-Mannose offers a natural, non-pharmacological alternative to antibiotics, with fewer side effects, making it an attractive option for consumers seeking preventive and therapeutic solutions.

2. Consumer Shift Toward Natural and Plant-Based Supplements

As health-conscious consumers increasingly prioritize natural and non-GMO products, D-Mannose is gaining popularity due to its plant-based origins and minimal impact on blood sugar levels. Its low glycemic index makes it suitable for diabetic patients, further expanding its appeal in the food alternate market.

3. Demand for Low-Calorie and Diabetic-Friendly Products

D-Mannose is absorbed slowly in the gastrointestinal tract and filtered out through the kidneys, unlike glucose, which is stored in the liver. This characteristic, combined with its low-calorie profile, makes it an ideal ingredient in functional foods and supplements catering to consumers seeking low-carbohydrate and diabetic-friendly options.

4. Growth in Preventive Healthcare

The global trend toward preventive healthcare is driving demand for D-Mannose, as consumers increasingly invest in supplements to maintain overall wellness. Rising awareness of bladder health and the risks associated with UTIs is prompting greater expenditure on preventive health solutions, particularly in regions like East Asia and North America.

Regional Insights

North America

North America, led by the United States, is a dominant market, projected to account for 73.1% of the region's total revenue by 2034. The region's strong demand is driven by high consumer awareness, a robust health supplement industry, and the increasing use of D-Mannose in both food source and functional foods. The preference for natural ingredients in food production further supports market growth in this region.

East Asia

East Asia is expected to hold a 25.2% share of global market revenue by 2034, with China leading the region with a projected 70% share of the East Asian market. The growth in China is attributed to the rising adoption of health supplements among health-conscious consumers and increased awareness of UTI prevention. The expanding e-commerce sector in the region is also facilitating greater access to D-Mannose products.

Market Trends

1. Rise of Combination Products

A notable trend in the D-Mannose market is the introduction of combination products that blend D-Mannose with other natural ingredients, such as cranberry extract and probiotics, to enhance efficacy and provide comprehensive urinary tract support. These products are gaining popularity due to their convenience and synergistic health benefits.

2. Preference for Capsules and Tablets

D-Mannose capsules and tablets are increasingly favored for their portability, travel-friendly nature, and longer shelf life compared to liquid forms. This convenience is driving consumer preference and contributing to the growth of these product formats.

3. Growth of Online Retail Channels

The rapid penetration of e-commerce platforms is transforming the distribution landscape for D-Mannose products. Online retail channels offer hassle-free purchasing options, making them a preferred choice for consumers. This trend is expected to further boost market accessibility and sales.

Competitive Landscape

The D-Mannose market features prominent players such as Nestlé Health Science, Pfanstiehl Inc., NOW Health Group, Inc., Vibrant Health, DuPont de Nemours, Inc., Source Naturals, Bio-Tech Pharmacal, Nutraceutical International Corporation, Swanson Vitamins, GNC Holdings, Inc., and NutriScience Innovations LLC. These companies are focusing on innovation, expanding product portfolios, and leveraging e-commerce to enhance market reach. Investments in research and development are also underway to explore additional health benefits of D-Mannose, such as its potential in supporting immune function and gut health.

Challenges and Opportunities

While the D-Mannose market is growing, challenges such as side effects from prolonged use, including gastric issues and potential kidney strain, may hinder adoption in some consumer segments. However, these challenges present opportunities for manufacturers to develop improved formulations and conduct clinical studies to reinforce consumer confidence. The rising demand for personalized nutrition and innovative delivery formats, such as powders, offers significant growth potential for market players.

Future Outlook

The D-Mannose market is expected to maintain steady growth through 2034, driven by increasing consumer awareness, the rising prevalence of UTIs, and the global shift toward natural and preventive healthcare solutions. With a projected market size of US$ 1.72 billion by 2034, D-Mannose is set to solidify its position as a key ingredient in the health and wellness industry. Manufacturers that invest in product innovation, sustainable sourcing, and strategic partnerships will be well-positioned to capitalize on emerging opportunities.

Browse Full Report: https://www.factmr.com/report/d-mannose-market

Conclusion

The global D-Mannose market is experiencing consistent growth, fueled by its role in addressing urinary tract health and aligning with consumer preferences for natural, low-calorie, and diabetic-friendly supplements. With strong regional demand in North America and East Asia, coupled with the rise of e-commerce and innovative product formulations, the market is poised for a promising future. As health consciousness continues to rise, D-Mannose will remain a vital component of preventive healthcare and functional nutrition.

Check out More Related Studies Published by Fact.MR:

Industrial Margarine Market: https://www.factmr.com/report/1092/industrial-margarine-market

Ammonia Caramel Market: https://www.factmr.com/report/1071/ammonia-caramel-market

Flour Treatment Agents Market: https://www.factmr.com/report/1104/flour-treatment-agent-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release D-Mannose Market Expected to Reach US$ 1.72 Billion by 2034 | Fact.MR here

News-ID: 4070830 • Views:

More Releases from Fact.MR

Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
Bioinformatics Market is Growing at a CAGR of 13.4% by 2034 | Fact.MR Report
The latest report on the Bioinformatics Market, projecting robust growth driven by the increasing demand for genomic research, advancements in artificial intelligence (AI), and the rising adoption of precision medicine. Valued at USD 14.29 billion in 2024, the global market is forecast to expand at a compound annual growth rate (CAGR) of 13.4%, reaching USD 50.25 billion by 2034. This significant growth underscores the critical role of bioinformatics in decoding
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Key Players: iRobot Corporation, Neato Robotics, Inc., Yujin Robot, Co., Ltd., and Dyson Inc
Residential Robotic Vacuum Cleaner Market to Reach USD 11.6 Billion by 2033 | Ke …
Fact.MR today released its latest report on the Residential Robotic Vacuum Cleaner Market, projecting robust growth driven by increasing demand for automation, busy lifestyles, and advancements in smart home technologies. Valued at USD 3.0 billion in 2023, the global market is forecast to expand at a compound annual growth rate (CAGR) of 14.4%, reaching USD 11.6 billion by 2033. This significant growth highlights the rising adoption of robotic vacuum cleaners
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
08-29-2025 | Health & Medicine
Fact.MR
Brain-Computer Interface Market is Estimated to Reach USD 6.5 Billion by 2033
The global brain-computer interface (BCI) market was valued at USD 1.6 billion in 2022 and is projected to reach USD 6.5 billion by 2033, growing at a compound annual growth rate (CAGR) of 13.6% from 2023 to 2033. This expansion reflects the increasing adoption of BCI technologies in medical applications, driven by advancements in neuroscience, AI, and sensor technologies. BCIs enable direct communication between the brain and external devices, offering
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2034 | Key Players: Johnson & Johnson Services Inc; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Takeda Pharmaceutical Company Limited
08-29-2025 | Health & Medicine
Fact.MR
Orally Disintegrating Tablet Market is Projected to Reach USD 72.68 Billion by 2 …
The global orally disintegrating tablet (ODT) market is valued at USD 24.45 billion in 2024 and is forecasted to expand at a compound annual growth rate (CAGR) of 11.5%, reaching USD 72.68 billion by 2034. This robust growth is driven by the increasing demand for patient-friendly dosage forms, particularly among the elderly, pediatric, and dysphagic populations, who benefit from ODTs' ease of administration without water and rapid dissolution. ODTs enhance

All 5 Releases


More Releases for UTI

Urinary Tract Infection (UTI) Treatment Market Expanding Solutions for Rising Gl …
Introduction The urinary tract infection (UTI) treatment market is witnessing significant growth, driven by the increasing prevalence of UTIs globally, rising awareness of treatment options, and advances in medical technologies. UTIs affect millions of individuals each year, with women being disproportionately impacted. As antibiotic resistance becomes an increasing concern and healthcare providers explore alternative solutions, the market for UTI treatments continues to evolve. This article explores the key factors driving the
Uncomplicated Urinary Tract Infection (UTI) Treatment Market Growing Demand for …
Introduction Urinary tract infections (UTIs) are among the most common bacterial infections affecting individuals worldwide, especially women. They occur when harmful bacteria enter the urinary tract, leading to inflammation and discomfort. While most UTIs are uncomplicated, meaning they are limited to the lower urinary tract (bladder and urethra), their frequency and impact on daily life highlight the importance of effective treatments. The UTI treatment market is experiencing significant growth, driven by
Retail Logistics Market Worth Observing Growth | Panalpina, Exel, UTi Worldwide
The latest launched report on Global Retail Logistics Market delivers a transformation framework to understand how megatrends affect industry growth, taking into account the major disrupting forces creating uncertainties for every organisation in the Retail Logistics. Based on these outcomes, HTF MI outline plan for these volatile scenarios considering companies such as APL Logistics, Schneider National, Maersk Logistics, SembCorp Logistics (USA), Panalpina, Exel, UTi Worldwide, Kuehne + Nagel International, DHL
Investigation for Investors in shares of Patterson-UTI Energy, Inc. (NASDAQ: PTE …
An investigation was announced concnering potential breaches of fiduciary duties by certain directors at Patterson-UTI Energy, Inc. Investors who purchased shares of Patterson-UTI Energy, Inc. (NASDAQ: PTEN) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Patterson-UTI Energy directors breached their fiduciary duties and caused damage to the company and its shareholders. Houston, TX based Patterson-UTI
UTI Treatment Market Therapeutic Assessment 2018-2023
Global and Chinese UTI Treatment Industry, 2018 Market Research Report: The 'Global and Chinese UTI Treatment Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global UTI Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the UTI Treatment manufacturers and is a valuable source of guidance and direction for companies and individuals
Prevalence of Complicated Urinary Tract Infection (UTI) to Increase Globally
Over 60% physicians are likely to prescribe penicillin and combinations to treat urinary tract infections (UTIs), whereas a vast majority prescribe quinolones in their daily practice to treat complicated cases. A significant percentage of physicians also agreed that they prescribed nitrofurans to treat uncomplicated urinary tract infections in female patients. FMI’s survey also found that cephalosporin is the second-most common drug in the treatment of recurrent and complicated urinary tract